|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles in PresS, published online ahead of print October 15, 2002
Am J Physiol Renal Physiol, 10.1152/ajprenal.00271.2002
Submitted on July 24, 2002
Accepted on October 8, 2002
1 Department of Anesthesiology, Columbia University, New York, NY, USA
2 Department of Pathology, Columbia University, New York, NY, USA
3 Department of Pharmacology, Merck Research Laboratories, West Point, PA, USA
* To whom correspondence should be addressed. E-mail: tl128{at}columbia.edu.
A3 adenosine receptor (AR) activation and inhibition worsens and improves, respectively, renal function after ischemic reperfusion (IR) injury in rats. We sought to further characterize the role of A3 ARs in modulating renal function after either IR or myoglobinuric renal injury. A3 knockout mice had significantly lower plasma creatinines compared to C57 controls 24 hrs after IR or myoglobinuric renal injury. C57 control mice pretreated with the A3 AR antagonist (MRS-1191) or agonist (IB-MECA, 0.125 mg/kg) demonstrated improved or worsened renal function, respectively, after IR or myoglobinuric renal injury. Higher doses of IB-MECA were lethal in C57 mice subjected to renal ischemia. H1 but not H2 histamine receptor antagonist prevented death in mice pretreated with IB-MECA before renal ischemia. Improvement in renal function was associated with significantly improved renal histology. In conclusion, pre-ischemic A3 AR activation (0.125 mg/kg IB-MECA) exacerbated renal IR injury in mice. Mice lacking A3 ARs or blocking A3 ARs in wild type mice resulted in significant renal protection from ischemic or myoglobinuric renal failure.
This article has been cited by other articles:
![]() |
H. T. Lee, S. W. C. Chen, T. C. Doetschman, C. Deng, V. D. D'Agati, and M. Kim Sevoflurane protects against renal ischemia and reperfusion injury in mice via the transforming growth factor-{beta}1 pathway Am J Physiol Renal Physiol, July 1, 2008; 295(1): F128 - F136. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Franco, R. Bautista, O. Perez-Mendez, L. Gonzalez, U. Pacheco, L. G. Sanchez-Lozada, J. Santamaria, E. Tapia, R. Monreal, and F. Martinez Renal interstitial adenosine is increased in angiotensin II-induced hypertensive rats Am J Physiol Renal Physiol, January 1, 2008; 294(1): F84 - F92. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Grenz, H. Zhang, J. Weingart, S. von Wietersheim, T. Eckle, J. Schnermann, C. Kohle, D. Kloor, C. H. Gleiter, V. Vallon, et al. Lack of effect of extracellular adenosine generation and signaling on renal erythropoietin secretion during hypoxia Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1501 - F1511. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. T. Lee, M. Kim, M. Kim, N. Kim, F. T. Billings IV, V. D. D'Agati, and C. W. Emala Sr. Isoflurane protects against renal ischemia and reperfusion injury and modulates leukocyte infiltration in mice Am J Physiol Renal Physiol, September 1, 2007; 293(3): F713 - F722. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Jo, M. H. Rosner, and M. D. Okusa Pharmacologic Treatment of Acute Kidney Injury: Why Drugs Haven't Worked and What Is on the Horizon Clin. J. Am. Soc. Nephrol., March 1, 2007; 2(2): 356 - 365. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. T. Lee, M. Kim, J. D. Joo, G. Gallos, J.-F. Chen, and C. W. Emala A3 adenosine receptor activation decreases mortality and renal and hepatic injury in murine septic peritonitis Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2006; 291(4): R959 - R969. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Vallon, B. Muhlbauer, and H. Osswald Adenosine and kidney function. Physiol Rev, July 1, 2006; 86(3): 901 - 940. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. McLaughlin, M. D. Alva, and M. Egea Adenosine receptor antagonism in acute tacrolimus toxicity Nephrol. Dial. Transplant., July 1, 2006; 21(7): 1961 - 1965. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. T. Lee, H. Xu, S. H. Nasr, J. Schnermann, and C. W. Emala A1 adenosine receptor knockout mice exhibit increased renal injury following ischemia and reperfusion Am J Physiol Renal Physiol, February 1, 2004; 286(2): F298 - F306. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |